- Home
- MNPR vs DH Comparison
MNPR vs DH Comparison
Compare MNPR & DH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNPR
- DH
- Stock Information
- Founded
- MNPR 2014
- DH 2011
- Country
- MNPR United States
- DH United States
- Employees
- MNPR N/A
- DH N/A
- Industry
- MNPR Biotechnology: Pharmaceutical Preparations
- DH Computer Software: Prepackaged Software
- Sector
- MNPR Health Care
- DH Technology
- Exchange
- MNPR Nasdaq
- DH Nasdaq
- Market Cap
- MNPR 244.1M
- DH 280.0M
- IPO Year
- MNPR 2019
- DH 2021
- Fundamental
- Price
- MNPR $39.59
- DH $2.53
- Analyst Decision
- MNPR Strong Buy
- DH Hold
- Analyst Count
- MNPR 5
- DH 11
- Target Price
- MNPR $59.50
- DH $5.35
- AVG Volume (30 Days)
- MNPR 27.1K
- DH 1.3M
- Earning Date
- MNPR 05-08-2025
- DH 05-06-2025
- Dividend Yield
- MNPR N/A
- DH N/A
- EPS Growth
- MNPR N/A
- DH N/A
- EPS
- MNPR N/A
- DH N/A
- Revenue
- MNPR N/A
- DH $252,202,000.00
- Revenue This Year
- MNPR N/A
- DH N/A
- Revenue Next Year
- MNPR N/A
- DH $2.81
- P/E Ratio
- MNPR N/A
- DH N/A
- Revenue Growth
- MNPR N/A
- DH 0.31
- 52 Week Low
- MNPR $1.72
- DH $2.15
- 52 Week High
- MNPR $54.30
- DH $7.57
- Technical
- Relative Strength Index (RSI)
- MNPR 57.10
- DH 36.31
- Support Level
- MNPR $26.06
- DH $2.15
- Resistance Level
- MNPR $40.90
- DH $2.63
- Average True Range (ATR)
- MNPR 4.78
- DH 0.18
- MACD
- MNPR 0.64
- DH 0.04
- Stochastic Oscillator
- MNPR 84.89
- DH 45.24
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicin for the treatment of soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About DH Definitive Healthcare Corp.
Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.